Medicrea reports Q1 sales of $7.43M — 3 takeaways

Written by Megan Wood | April 14, 2017 | Print  |

Lyon, France-based Medicrea reported quarter one 2017 sales of $7.43 million.

Here are three takeaways:


1. Medicrea saw a 38 percent increase in U.S. cases leveraging the UNiD Rods.


2. In Q1, the company moved all manufacturing operations from its La Rochelle site to a new facility in Rillieux-la-Pape.


3. The company will highlight its UNiD Adaptive Spine Intelligence and patient-specific implants at the International Society for the Advancement of Spine Surgery annual meeting, in Boca Raton, Fla., from April 12 to 14.


More articles on devices:
Medical device industry outlook in 2017: 5 thoughts from AdvaMed President and CEO Scott Whitaker
Bridging the gap between new spine technology & patients — The role of the Medical Science Liaison
Meeting to highlight 9M implanted PEEK-OPTIMA devices & more: 5 notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months